Phase I Study of the Intravenous Administration of Attenuated Salmonella typhimurium to Patients With Metastatic Melanoma JF Toso, VJ Gill, P Hwu, FM Marincola, NP Restifo, DJ Schwartzentruber, ... Journal of clinical oncology 20 (1), 142-152, 2002 | 897 | 2002 |
C-reactive protein in patients with COPD, control smokers and non-smokers VM Pinto-Plata, H Müllerova, JF Toso, M Feudjo-Tepie, JB Soriano, ... Thorax 61 (1), 23-28, 2006 | 716 | 2006 |
Profiling serum biomarkers in patients with COPD: associations with clinical parameters V Pinto-Plata, J Toso, K Lee, D Park, J Bilello, H Mullerova, MM De Souza, ... Thorax 62 (7), 595-601, 2007 | 262 | 2007 |
CD4+ blood dendritic cells are potent producers of IFN-alpha in response to in vitro HIV-1 infection. JJ Ferbas, JF Toso, AJ Logar, JS Navratil, CR Rinaldo Jr Journal of immunology (Baltimore, Md.: 1950) 152 (9), 4649-4662, 1994 | 188 | 1994 |
Human cytotoxic T-cell lines with restricted specificity for squamous cell carcinoma of the head and neck S Yasumura, H Hirabayashi, DR Schwartz, JF Toso, JT Johnson, ... Cancer research 53 (6), 1461-1468, 1993 | 127 | 1993 |
Efficient gene transfer to human peripheral blood monocyte-derived dendritic cells using human immunodeficiency virus type 1-based lentiviral vectors N Chinnasamy, D Chinnasamy, JF Toso, R Lapointe, F Candotti, ... Human gene therapy 11 (13), 1901-1909, 2000 | 108 | 2000 |
Human dendritic cells require multiple activation signals for the efficient generation of tumor antigen‐specific T lymphocytes R Lapointe, JF Toso, C Butts, HA Young, P Hwu European journal of immunology 30 (11), 3291-3298, 2000 | 106 | 2000 |
Effects of interleukin-18 on natural killer cells: costimulation of activation through Fc receptors for immunoglobulin S Srivastava, D Pelloso, H Feng, L Voiles, D Lewis, Z Haskova, ... Cancer immunology, immunotherapy 62, 1073-1082, 2013 | 88 | 2013 |
MAGE-1-specific precursor cytotoxic T-lymphocytes present among tumor-infiltrating lymphocytes from a patient with breast cancer: characterization and antigen-specific activation JF Toso, C Oei, F Oshidari, J Tartaglia, E Paoletti, HK Lyerly, S Talib, ... Cancer research 56 (1), 16-20, 1996 | 81 | 1996 |
Replication-Defective Canarypox (ALVAC) Vectors Effectively Activate Anti–Human Immunodeficiency Virus-1 Cytotoxic T Lymphocytes Present in Infected Patients: Implications for … G Ferrari, C Berend, J Ottinger, R Dodge, J Bartlett, J Toso, D Moody, ... Blood, The Journal of the American Society of Hematology 90 (6), 2406-2416, 1997 | 69 | 1997 |
Chemoimmunotherapy using pegylated liposomal doxorubicin and interleukin-18 in recurrent ovarian cancer: a phase I dose-escalation study F Simpkins, A Flores, C Chu, JS Berek, J Lucci III, S Murray, J Bauman, ... Cancer immunology research 1 (3), 168-178, 2013 | 54 | 2013 |
Safety, tolerability, pharmacokinetics and pharmacodynamics of an anti-oncostatin M monoclonal antibody in rheumatoid arthritis: results from phase II randomized, placebo … EH Choy, M Bendit, D McAleer, F Liu, M Feeney, S Brett, S Zamuner, ... Arthritis research & therapy 15, 1-10, 2013 | 50 | 2013 |
Oligoclonal CD8 Lymphocytes from Persons with Asymptomatic Human Immunodeficiency Virus (HIV) Type 1 Infection Inhibit DIV-1 Replication JF Toso, CH Chen, JR Mohr, L Piglia, C Dei, G Ferrari, ML Greenberg, ... Journal of Infectious Diseases 172 (4), 964-973, 1995 | 48 | 1995 |
A dose-escalation study of recombinant human interleukin-18 in combination with rituximab in patients with non-Hodgkin lymphoma MJ Robertson, J Kline, H Struemper, KM Koch, JW Bauman, OS Gardner, ... Journal of Immunotherapy 36 (6), 331-341, 2013 | 46 | 2013 |
Use of proteomic patterns of serum biomarkers in patients with chronic obstructive pulmonary disease: correlation with clinical parameters V Pinto-Plata, J Toso, K Lee, J Bilello, H Mullerova, M De Souza, ... Proceedings of the American Thoracic Society 3 (6), 465-466, 2006 | 30 | 2006 |
Association of alpha interferon production with natural killer cell lysis of U937 cells infected with human immunodeficiency virus G Rappocciolo, JF Toso, DJ Torpey 3rd, P Gupta, CR Rinaldo Jr Journal of clinical microbiology 27 (1), 41-48, 1989 | 30 | 1989 |
Combination therapy with ofatumumab and bendamustine in xenograft model of chronic lymphocytic leukaemia Z Haskova, MN Whitacre, KA Dede, JM Lee, SH Trulli, M Ciucci, JF Toso, ... British journal of haematology 156 (3), 402-404, 2012 | 8 | 2012 |
CD40 ligand and lipopolysaccharide enhance the in vitro generation of melanoma-reactive T-cells JF Toso, R Lapointe, P Hwu Journal of immunological methods 259 (1-2), 181-190, 2002 | 7 | 2002 |
A phase I, dose escalation trial to assess the safety and biological activity of recombinant human interleukin-18 (SB-485232) in combination with pegylated liposomal … F Simpkins, AM Flores, C Chu, JA Lucci, JS Berek, G Coukos, ... Journal of Clinical Oncology 30 (15_suppl), 5065-5065, 2012 | 5 | 2012 |
A phase I trial evaluating the safety and biological activity of iboctadekin (rhIL-18) in combination with rituximab in patients with CD20+ B-cell non-Hodgkin's lymphoma MJ Robertson, J Kline, J Bauman, O Gardner, Z Jonak, KM Koch, ... Journal of Clinical Oncology 27 (15_suppl), 8566-8566, 2009 | 4 | 2009 |